Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2001
06/19/2001US6248544 Immunoassay using antibody that binds tartrate-resistant acid phosphatase present in body fluid sample; determining enzyme activity at ph 5.7 to 6.3
06/19/2001US6248543 Detecting microbiocides in sample; mix modulator and protein in sample and detect binding of modulator and protein
06/19/2001US6248541 Generating homogeneous cell aggregations by culture cells in confining amount of nutrients
06/19/2001US6248537 Use of the combing process for the identification of DNA origins of replication
06/19/2001US6248536 Bacillus thuringiensis CryET33 and CryET34 compositions and uses thereof
06/19/2001US6248535 Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
06/19/2001US6248534 Method for determining the detection value of a target RNA
06/19/2001US6248533 Gene diagnosis of diseases wherein TNF-α promotors participate
06/19/2001US6248532 Detecting modulators of regulatory element; incubate nucleotide sequences with modulators, monitor binding to nucleotide sequences, comparing binding in the presence and absence modulators
06/19/2001US6248529 Method of chemically assembling nano-scale devices
06/19/2001US6248528 Drug screening by contacting test compound with human centrin protein and determining whether compound binds to protein
06/19/2001US6248527 Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E
06/19/2001US6248526 Detecting target nucleotide sequences in sample; incubate sample with primers, expose sample to polymerase with accuracy activity, detect and/or measure release of signal
06/19/2001US6248524 Detecting genetic disorders associated with genome adjustment; pool genetic material samples, recover sample with preferential alleles, monitor gene expression in test sample
06/19/2001US6248523 Mammalian tumor susceptibility genes and their uses
06/19/2001US6248522 Treating sample with enzyme to degrade contaminant nucleic acids, deactivating enzyme, then amplifying target nucleic acid; sample is also mixed with reagent that prevents reactivation of degradation enzyme
06/19/2001US6248521 Dew point in chamber is maintained to prevent evaporation of solution at discrete points of solid phase substrate where reactions are taking place
06/19/2001US6248519 Detection of fermentation-related microorganisms
06/19/2001US6248518 Attaching dyes to probe, hybridizing to dna sequence, recording value of emissions, heating, monitoring temperature at which emissions are reduced, and determining observed melting point; reduced melting point indicates mutation
06/19/2001US6248517 Amino acid sequences; diagnosis of lyme disease; recombinant production; vaccines
06/19/2001US6248516 Library for expression of immunoglobulin heavy chain variable domains
06/19/2001US6248515 Methods for the early detection of HIV infection
06/19/2001US6248513 In vitro detection of infection of cells by microorganism; incubate immunoglobulins with cells and detect the formation of protein immunoglobulin complexes
06/19/2001US6248330 Genetic engineering; polypeptides
06/19/2001CA2040180C Enzymatic process for the determination of beta-lactam antibiotics
06/19/2001CA2004068C Hair analysis method
06/14/2001WO2001042794A2 Method for identifying inhibitors of cytokinesis
06/14/2001WO2001042789A1 MARKERS FOR IDENTIFICATION AND ISOLATION OF PANCREATIC ISLET α AND β CELL PROGENITORS
06/14/2001WO2001042784A2 Methods for screening compounds active on neurons
06/14/2001WO2001042782A1 Characterization of hybridized polymer molecules based on monomer-interface interactions
06/14/2001WO2001042781A2 Supracolonic aerodigestive neoplasm detection
06/14/2001WO2001042768A1 Surface plasmon resonance
06/14/2001WO2001042512A2 Normalization controls and duplex probes for quantitative hybridization reactions
06/14/2001WO2001042511A2 Ibd-related polymorphisms
06/14/2001WO2001042510A2 Method for selectively isolating a nucleic acid
06/14/2001WO2001042509A1 Use of multiple recombination sites with unique specificity in recombinational cloning
06/14/2001WO2001042508A2 Methods and compositions relating to electrical detection of nucleic acid reactions
06/14/2001WO2001042507A1 Fluorescent in situ rt-pcr
06/14/2001WO2001042506A1 T1 receptor-like ligand ii and uses thereof
06/14/2001WO2001042505A2 Fluorescent quenching detection reagents and methods
06/14/2001WO2001042504A2 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum
06/14/2001WO2001042503A2 Apparatus and methods for drug screening based on nucleic acid analysis
06/14/2001WO2001042502A2 Methods for disease detection
06/14/2001WO2001042500A2 Testing xenografts and sources thereof for retrovirus
06/14/2001WO2001042498A1 Method of detecting nucleotide polymorphism
06/14/2001WO2001042497A2 Monitoring oligonucleotide binding processes using chemiluminescence quenching
06/14/2001WO2001042496A2 A method of assessing the amount of nucleic acid in a sample
06/14/2001WO2001042495A2 Products comprising a support whereon are fixed nucleic acids and their use as dna chip
06/14/2001WO2001042494A2 Test system for detecting analytes, a method for the production thereof and its use
06/14/2001WO2001042493A2 Method for the parallel detection of the degree of methylation of genomic dna
06/14/2001WO2001042491A2 Novel enzymatic substrates for detecting pseudomonas aeruginosa
06/14/2001WO2001042490A2 Novel alizarin-based chromogenic substrates
06/14/2001WO2001042488A2 Plasminogen activator assay involving an elastase inhibitor
06/14/2001WO2001042487A2 Device for extraction of nucleic acids
06/14/2001WO2001042472A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE
06/14/2001WO2001042471A2 Polypeptides and polynucleotides encoding same
06/14/2001WO2001042467A2 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
06/14/2001WO2001042462A2 Phospholipase a2 inhibitory peptides from python reticulatus
06/14/2001WO2001042458A1 Method of examining vulgar psoriasis
06/14/2001WO2001042451A2 FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS
06/14/2001WO2001042449A2 Methods for introducing genes into mammalian subjects
06/14/2001WO2001042446A2 A functional gene array in yeast
06/14/2001WO2001042437A2 Histone deacetylase-8 proteins, nucleic acids, and methods of use
06/14/2001WO2001042429A1 Infection of eukaryotic cells with viruses in vitro
06/14/2001WO2001042422A2 Acyl glucosaminyl inositol amidase family and methods of use
06/14/2001WO2001042307A1 MUTANT ERα AND TEST SYSTEMS FOR TRANSACTIVATION
06/14/2001WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof
06/14/2001WO2001042301A1 Interferon-alpha induced gene
06/14/2001WO2001042299A2 Hepatitis virus sentinel virus i (svi)
06/14/2001WO2001042288A2 G-protein coupled receptors
06/14/2001WO2001042285A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them
06/14/2001WO2001042281A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis
06/14/2001WO2001042273A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/14/2001WO2001042211A2 Detection of transmembrane potentials by optical methods
06/14/2001WO2001041815A2 Metastasis genes and uses thereof
06/14/2001WO2001041801A2 Mutant simplex virus for treating unwanted hyperproliferative cell growth
06/14/2001WO2001041752A2 Use of isoform specific inhibitors of cgmp-dependent protein kinase for treatment of pain
06/14/2001WO2001041558A1 Hybrid winter oilseed rape and methods for producing same
06/14/2001WO2001016860A3 Artificial intelligence system for genetic analysis
06/14/2001WO2001014878A9 Method and kit for detecting betalactam-containing compounds
06/14/2001WO2001009372B1 Chemiluminescent substrates of hydrolytic enzymes such as phosphatases
06/14/2001WO2001009189A3 Compositions and methods for the treatment of tumors
06/14/2001WO2001003720A3 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
06/14/2001WO2001000829A8 Human endogenous retrovirus in breast cancer
06/14/2001WO2001000812A3 22012, a novel human carboxypeptidase
06/14/2001WO2000071747A3 Detection system for separating constituents of a sample and production and use of the same
06/14/2001WO2000070096A3 Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus
06/14/2001WO2000035950A9 Reagents and methods useful for detecting diseases of the breast
06/14/2001WO2000032631A3 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/14/2001US20010003743 Consisting of a polynucleotide encoding the polypeptide comprising amino acid 1 to 578 of a specific amino acid sequence, a polynucleotide capable of hybridizing to above polynuceotide and a fragment of both polynucleotides
06/14/2001US20010003652 Relating to sample processing
06/14/2001US20010003650 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries
06/14/2001US20010003649 Nucleic acid-immobilized substrate
06/14/2001US20010003648 Screening multiplicity of different molecules know to bind to particular class of protein for their ability to modify the stability of the protein which indicates the molecule binds the protein, generating activity spectrum for protein
06/14/2001US20010003647 Exposing electrochemiluminescent label linked to a coreactant to condition suitable for inducing a electrochemiluminescence
06/14/2001CA2396795A1 Fluorescent quenching detection reagents and methods
06/14/2001CA2396739A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis
06/14/2001CA2395047A1 Method for the parallel detection of the degree of methylation of genomic dna
06/14/2001CA2395039A1 Method for identifying inhibitors of cytokinesis
06/14/2001CA2394962A1 A functional gene array in yeast